{"id":27628,"date":"2026-01-11T02:08:22","date_gmt":"2026-01-11T07:08:22","guid":{"rendered":"https:\/\/citystuff.com\/new-york\/2026\/01\/11\/tiny-patch-could-replace-painful-ivf-shots\/"},"modified":"2026-01-11T02:08:23","modified_gmt":"2026-01-11T07:08:23","slug":"tiny-patch-could-replace-painful-ivf-shots","status":"publish","type":"post","link":"https:\/\/citystuff.com\/new-york\/2026\/01\/11\/tiny-patch-could-replace-painful-ivf-shots\/","title":{"rendered":"Tiny Patch Could Replace Painful IVF Shots"},"content":{"rendered":"

Introduction to IVF and its Challenges<\/h2>\n

Every year, hundreds of thousands of women across the country undergo IVF, a physically and emotionally draining process that involves retrieving multiple eggs from the ovaries and fertilizing them with sperm in a lab. In the weeks leading up to egg retrieval, patients must inject themselves with hormones at precise times each day \u2014 a routine often described as one of the most stressful and painful parts of IVF.<\/p>\n

The Breakthrough: A Light-Activated Microneedle Patch<\/h2>\n

Now, scientists at McGill University may have found a way to ease that burden. They\u2019ve developed a light-activated microneedle patch that can deliver hormones automatically at the right time, making the process less painful \u2014 and potentially increasing the chances of a successful pregnancy. \u201cIVF success rates are at best 30%, even for the youngest women,\u201d Vivienne Tam, a PhD student at McGill who was the lead author of the study, said in a press release. \u201cThe hope is that if you take out the human error with injecting yourself and deliver the drug at times optimized for each patient, you could potentially see this success rate go up.\u201d<\/p>\n

How the Patch Works<\/h2>\n

The delivery system relies on a hydrogel microneedle patch packed with specially engineered nanoparticles that store and release a key IVF hormone, leuprolide, when activated by near-infrared light. To build it, the team first determined how many hormone-loaded nanoparticles each microneedle could hold without compromising its ability to penetrate the skin. Next, they tested whether the light could reliably release the hormone in a porcine skin model over two hours. Finally, they demonstrated that even a short five-minute pulse of light could deliver measurable levels of leuprolide into the skin, bloodstream, and organs of a live rat.<\/p>\n

Advantages Over Previous Designs<\/h2>\n

\u201cThe light can also be programmed to release the drug at the specific time the drug is needed, which could differ for each individual,\u201d Tam said. While the concept of light-triggered drug delivery isn\u2019t new, earlier attempts ran into a key obstacle: they often released foreign substances into the body, raising serious safety and regulatory concerns. But McGill\u2019s new patch avoids that problem entirely. \u201cThis is the first time that we were able to show light-triggered drug release from a nanoparticle-microneedle composite without releasing any foreign substance into the body,\u201d said Marta Cerruti, a materials engineering professor and senior author of the study.<\/p>\n

Impact and Future Applications<\/h2>\n

The development comes as demand for IVF continues to rise, driven by advances in medical technology, increased awareness and wider employer coverage. At the same time, couples waiting longer to have children, along with declining fertility rates, have made IVF an increasingly common route to parenthood. The researchers said the innovative drug delivery system could one day help anyone who relies on daily injections, including those with diabetes, rheumatoid arthritis and multiple sclerosis. Looking ahead, they plan to refine the system\u2019s dosing, explore hormone release profiles and investigate commercial possibilities.<\/p>\n

Conclusion<\/h2>\n

The breakthrough of a light-activated microneedle patch for IVF hormone delivery marks a significant step towards making the process less painful and potentially more successful. By avoiding the release of foreign substances into the body, this technology addresses a critical safety concern that has hindered previous designs. As IVF continues to become a more common route to parenthood, innovations like this patch could drastically change the experience of patients undergoing fertility treatments.<\/p>\n

FAQs<\/h2>\n